ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981